网友您好, 请在下方输入框内输入要搜索的题目:

题目内容 (请给出正确答案)
名词解释题
多中心临床试验(multicenter clinical trial)

参考答案

参考解析
解析: 暂无解析
更多 “名词解释题多中心临床试验(multicenter clinical trial)” 相关考题
考题 扩大的多中心临床试验是A.Ⅳ期临床试验B.Ⅲ期临床试验C.Ⅱ期临床试验D.Ⅰ期临床试验E.临床前研究

考题 循证药物信息的主体是A、临床试验B、多中心、大样本对照的临床试验C、随机、双盲、对照的临床试验D、多中心、双盲、对照的临床试验E、多中心、大样本、随机、双盲、对照的临床试验

考题 在多中心临床试验中应加强监查员的职能。()

考题 循证药物信息的主体是A.多中心、小样本、随机、双盲、对照的临床试验B.多中心、大样本、双盲、对照的临床试验C.多中心、小样本、随机、对照的临床试验D.多中心、大样本、随机、双盲、对照的临床试验E.多中心、大样本、双盲、对照的临床试验

考题 扩大的多中心临床试验是

考题 共用题干 Clinical Trials1. Many clinical trials are done to see if a new drug or device is safe and effective for people to use.Sometimes clinical trials are used to study different ways to use the standard treatments so they will be more effective,easier to use,and/or decrease side effects.Sometimes,studies are done to learn how to best use the treatment in a different population,such as children,in whom the treatment was not previously tested.2. It is important to test drugs and medical products in the people they are meant to help.It is also important to conduct research in a variety of people because different people may respond differently to treatments.Some people participate in clinical trials because they have exhausted standard treatment options .Other people participate in trials because they want to contribute to the ad-vancement of medical knowledge.3. The FDA(食品及药物管理局)works to protect participants in clinical trials and to ensure that people have reliable information as they decide whether to join a clinical trial.Although efforts are made to control the risks to clinical trial participants,some risks may be unavoidable because of the uncertainty inherent(内在的)in medical research studies involving new medical treatments.4. People should learn as much as possible about the clinical trials that interest them.They should also feel comfortable discussing their questions and concerns with members of the health care team. Prospective(预期的)participants should understand what happens during the trial ,the type of health care they will receive,and any costs to them.Anyone considering a clinical trial should also know that there are benefits and risks associated with participating. Paragraph 2______A: Are clinical trials safe?B: What are clinical trials?C: What should people know before participating in a clinical trial?D: Who should consider clinical trials and why?E: Where are clinical trials conducted?F: Why are clinical trials done?

考题 共用题干 Clinical Trials1 Many clinical trials are done to see if a new drug or device is safe and effective for people to use .Sometimes clinical trials are used to study different ways to use the standard treatments so they will be more effective,easier to use,and/or decrease side effects. Sometimes,studies are done to learn how to best use the treatment in a different group, such as children,in whom the treatment was not previously tested.2 It is important to test drugs and medical products in the people they are meant to help,It is also important to conduct research in a variety of people because different people mayrespond differently to treatments.Some people participate in clinical trials because they have exhausted standard treatment options.Other people participate in trials because they want to contribute to the advancement of medical knowledge.3 The FDA(食品及药物管理局)works to protect participants in clinical trials and to ensure that people have reliable information as they decide whether to join a clinical trial. Although efforts are made to control the risks to clinical trial participants,some risks may be unavoidable because of the uncertainty inherent(内在的)in medical research studies involving new medical treatments.4 People should learn as much as possible about the clinical trials that interest them.They should also feel comfortable discussing their questions and concerns with members of thehealth care team. Prospective(预期的)participants should understand what happens during the trial,the type of health care they will receive,and any costs to them.Anyone considering a clinical trial should also know that there are benefits and risks associated with participating. Reliable information should be available to_________.A: for some patientsB: before participationC: in humansD:medical knowledgeE: during the trialF: candidates for clinical trials

考题 共用题干 Clinical Trials1. Many clinical trials are done to see if a new drug or device is safe and effective for people to use.Sometimes clinical trials are used to study different ways to use the standard treatments so they will be more effective,easier to use,and/or decrease side effects.Sometimes,studies are done to learn how to best use the treatment in a different population,such as children,in whom the treatment was not previously tested.2. It is important to test drugs and medical products in the people they are meant to help.It is also important to conduct research in a variety of people because different people may respond differently to treatments.Some people participate in clinical trials because they have exhausted standard treatment options .Other people participate in trials because they want to contribute to the ad-vancement of medical knowledge.3. The FDA(食品及药物管理局)works to protect participants in clinical trials and to ensure that people have reliable information as they decide whether to join a clinical trial.Although efforts are made to control the risks to clinical trial participants,some risks may be unavoidable because of the uncertainty inherent(内在的)in medical research studies involving new medical treatments.4. People should learn as much as possible about the clinical trials that interest them.They should also feel comfortable discussing their questions and concerns with members of the health care team. Prospective(预期的)participants should understand what happens during the trial ,the type of health care they will receive,and any costs to them.Anyone considering a clinical trial should also know that there are benefits and risks associated with participating. Learn as much as you can about a clinical trial______.A: candidates for clinical trialsB: during the trialC: medical knowledgeD: in humansE: before participationF: for some patients

考题 共用题干 Clinical Trials1. Many clinical trials are done to see if a new drug or device is safe and effective for people to use.Sometimes clinical trials are used to study different ways to use the standard treatments so they will be more effective,easier to use,and/or decrease side effects.Sometimes,studies are done to learn how to best use the treatment in a different population,such as children,in whom the treatment was not previously tested.2. It is important to test drugs and medical products in the people they are meant to help.It is also important to conduct research in a variety of people because different people may respond differently to treatments.Some people participate in clinical trials because they have exhausted standard treatment options .Other people participate in trials because they want to contribute to the ad-vancement of medical knowledge.3. The FDA(食品及药物管理局)works to protect participants in clinical trials and to ensure that people have reliable information as they decide whether to join a clinical trial.Although efforts are made to control the risks to clinical trial participants,some risks may be unavoidable because of the uncertainty inherent(内在的)in medical research studies involving new medical treatments.4. People should learn as much as possible about the clinical trials that interest them.They should also feel comfortable discussing their questions and concerns with members of the health care team. Prospective(预期的)participants should understand what happens during the trial ,the type of health care they will receive,and any costs to them.Anyone considering a clinical trial should also know that there are benefits and risks associated with participating. Clinical trials provide the only hope______.A: candidates for clinical trialsB: during the trialC: medical knowledgeD: in humansE: before participationF: for some patients

考题 循证药物信息的主体是A:临床经验B:多中心、样本对照的临床试验C:随机、双盲、对照的临床试验D:多中心、大样本、随机、双盲、对照的临床试验E:多中心、随机、双盲、对照、数理统计的临床试验

考题 循证药物信息的主体是( )A:多中心、大样本、随机、双盲、对照的临床试验 B:多中心、双盲、对照的临床试验 C:随机、双盲、对照的临床试验 D:多中心、大样本的临床试验 E:大样本、对照的临床试验

考题 对目标适应证患者(多中心试验)治疗作用的初步评价()AⅠ期临床试验BⅡ期临床试验CⅢ期临床试验DⅣ期临床试验EⅤ期临床试验

考题 以下说法错误的为()A、多中心临床试验要求同时开始,但可以不同时结束。B、多中心临床试验由申办者总负责,并作为临床试验各中心间的协调人。C、多中心临床试验由一位主要研究者总负责,并作为临床试验各中心间的协调人。D、多中心临床试验方案及附件起草后由各中心主要研究者共同讨论制定,经申办者同意,伦理委员会批准后执行。

考题 对目标适应证患者(多中心试验)治疗作用的初步评价的是()A、Ⅰ期临床试验B、Ⅱ期临床试验C、Ⅴ期临床试验D、Ⅳ期临床试验E、Ⅲ期临床试验

考题 评价干预措施效果的最佳证据来自()A、一个随机对照临床试验B、一个多中心随机对照临床试验C、一个多中心临床试验D、传统的文献综述E、随机对照临床试验的系统综述和meta分析

考题 多中心临床试验由一位主要研究者总负责,并作为临床试验各中心间的协调人。

考题 多中心试验,各中心临床试验样本大小及中心间的分配应符合()的要求。

考题 多中心临床试验由申办者总负责,并作为临床试验各中心间的协调人。

考题 多中心临床试验要求各中心同期进行临床试验。

考题 以下说法正确的为()A、多中心临床试验应建立标准化的评价方法,试验中所采用的实验室和临床评价方法均应有质量控制,或由多中心实验室进行。B、多中心临床试验的数据资料应集中管理与分析,并建立数据传递与查询程序。C、多中心临床试验应建立管理办法以使各试验中心的研究者遵从试验方案,包括在违背方案时中止其继续参加试验的措施。D、在多中心临床试验中应加强监查员的职能

考题 多中心临床试验(multicenter clinical trial)

考题 临床试验(clinical trial)

考题 名词解释题临床试验(clinical trial)

考题 判断题多中心临床试验由申办者总负责,并作为临床试验各中心间的协调人。A 对B 错

考题 多选题以下说法错误的为()A多中心临床试验要求同时开始,但可以不同时结束。B多中心临床试验由申办者总负责,并作为临床试验各中心间的协调人。C多中心临床试验由一位主要研究者总负责,并作为临床试验各中心间的协调人。D多中心临床试验方案及附件起草后由各中心主要研究者共同讨论制定,经申办者同意,伦理委员会批准后执行。

考题 名词解释题药物临床试验(drug clinical trial)

考题 判断题多中心临床试验要求各中心同期进行临床试验。A 对B 错